Gad Heilweil

Gad Heilweil, MD is an Associate Professor of Ophthalmology at the University of California, Los Angeles (UCLA) Department of Ophthalmology and practices at the Doheny Eye Center UCLA in Pasadena. He specializes in medical and surgical retina care, offering advanced treatments for age-related macular degeneration (AMD), diabetic retinopathy, retinal vein occlusions, and macular dystrophies. He also serves on academic committees and trains future ophthalmologists.

• Education:
  • MD, Ruth & Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology (1997)
  • Ophthalmology Residency, Tel Aviv Sourasky Medical Center (2009)
  • Research Fellowship in Vitreo-Retinal Surgery, Jules Stein Eye Institute at UCLA (2012)

Dr. Heilweil’s research focuses on innovative treatments for retinal diseases, including stem cell therapies and gene therapies for AMD and Stargardt’s macular dystrophy. His work spans clinical trials, multi-center studies, and advanced ocular imaging.

His publications highlight expertise in retinal vascular diseases, gene therapy, stem cell transplantation, and anti-VEGF treatments. Key trends include quantification of retinal ischemia, adjunctive therapies for AMD, and surgical innovations for complex retinal conditions.

• Scientific Awards:
  • American Academy of Ophthalmology Best Poster Award
  • Top Doctor, Pasadena Magazine
  • Top Doctor, Los Angeles Magazine

Dr. Heilweil is actively involved in training ophthalmologists and integrating state-of-the-art technology into clinical practice. He is affiliated with Ronald Reagan UCLA Medical Center and accepts multiple insurance providers.